<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02375906</url>
  </required_header>
  <id_info>
    <org_study_id>HepNet-HDIN</org_study_id>
    <nct_id>NCT02375906</nct_id>
  </id_info>
  <brief_title>The Hepatitis Delta International Network</brief_title>
  <acronym>HDIN</acronym>
  <official_title>Hepatitis Delta Registry and Research Network- Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HepNet Study House, German Liverfoundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Center for Infection Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MHH-Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HepNet Study House, German Liverfoundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatitis delta is a major health problem, not only because of the severity of the disease,
      but also due to the lack of effective antiviral treatment. To improve the current therapeutic
      options, a better understanding of the pathophysiology is essential. Reliable research in
      this direction is only possible with large patient study groups. However, given the
      geographic distribution of hepatitis delta, larger patient cohorts would only be possible
      through multicenter collaboration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hepatitis international network cohort is a multicenter, observational study that will
      build up a research registry of HDV patients all over the world.

      The aims of this project are:

      i. Collect clinical information from hepatitis delta patients from multiple centers
      distributed worldwide in order to build up a large database that will enable and facilitate
      further research on chronic hepatitis delta.

      ii. To better inform patients about their viral infection, present status and evolution of
      liver disease throughout time. To give them the tools needed to inform other peers and
      medical professionals about the significance and consequences of a chronic hepatitis delta
      infection.

      iii. To allow the participating physicians to track course of the disease, therapies, signs
      and symptoms of the hepatitis delta patients included by their center.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Proportion of chronic hepatitis B patients with chronic hepatitis D infection worldwide</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HDV-RNA HBsAg</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HBV-DNA</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of treated chronic hepatitis B patients with chronic hepatitis D infection worldwide</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Hepatitis D</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic hepatitis delta will be screened regardless of HDV or HBV genotype
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Positive HBs antigen and antiHDV for longer than 6 months.

        Exclusion Criteria:

        Absence of any cause of relevant liver disease other than HDV (i.e. hemochromatosis,
        autoimmune hepatitis, alcoholic or toxic liver disease, etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael P Manns, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hannover Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heiner Wedemeyer, Prof.Dr.</last_name>
    <email>heiner.wedemeyer@uk-essen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Petra Dörge, Dr.</last_name>
    <email>doerge.petra@mh-hannover.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Vienna; Internal Med.III</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Ferenci, Prof. dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Swoboda</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Antwerpen University Hospital</name>
      <address>
        <city>Edegem</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Vanwolleghem, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Erwin Ho</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centro de Pesquisa em Medicina Tropical</name>
      <address>
        <city>Rondonia</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Miguel Villalobos Salcedo</last_name>
    </contact>
    <contact_backup>
      <last_name>Lourdes M Bozacov</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical Center Mrcheveli</name>
      <address>
        <city>Tiflis</city>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Metreveli, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Irakli Rtskhiladze, Dr</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medizinisches Infektiologiezentrum</name>
      <address>
        <city>Berlin</city>
        <zip>10439</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Ingiliz, Dr.med.</last_name>
    </contact>
    <investigator>
      <last_name>A Baumgarten, Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik I Charite- Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion Muche, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Christina Grunow</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Giessen-Marburg</name>
      <address>
        <city>Gießen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janina Trauth, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Cornberg, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dep.of Medicine University of Thessalony</name>
      <address>
        <city>Larissa</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg N Dalekos, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Zachoo Kalliopi, Dr.</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centro di ricerca per lo studio della Epatiti</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefano Brillianti, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Casa Sollievo della Sofferenza Hospital</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grazia A Niro, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Citta della Salute e della Scienza di Torino</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Rizzetto, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Antonella Olivero</last_name>
      <email>antonella.olivero@unito.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The University of Medicine &quot;Nicolae Testimitanu&quot;</name>
      <address>
        <city>Chisinau</city>
        <country>Moldova, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adela Turcanu, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dept.of Medicine Aga Khan University</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saeed Hamid, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liverstomach Clinic</name>
      <address>
        <city>Karachi</city>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zaigham Abbas, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital of Infectious Disease &quot;dr. Victor Babes&quot;</name>
      <address>
        <city>Bucharest</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ceausu Emanoil, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>George Gherlan, Dr.</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d´Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Buti, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Adriana Palom</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vietnamese-German Center for Medical Research</name>
      <address>
        <city>Hanoi</city>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thirumalaisamy P Velavan</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Georgia</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Moldova, Republic of</country>
    <country>Pakistan</country>
    <country>Romania</country>
    <country>Spain</country>
    <country>Vietnam</country>
  </location_countries>
  <removed_countries>
    <country>Russian Federation</country>
    <country>Turkey</country>
  </removed_countries>
  <results_reference>
    <citation>Wranke A, Pinheiro Borzacov LM, Parana R, Lobato C, Hamid S, Ceausu E, Dalekos GN, Rizzetto M, Turcanu A, Niro GA, Lubna F, Abbas M, Ingiliz P, Buti M, Ferenci P, Vanwolleghem T, Hayden T, Dashdorj N, Motoc A, Cornberg M, Abbas Z, Yurdaydin C, Manns MP, Wedemeyer H, Hardtke S; Hepatitis Delta International Network. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN). Liver Int. 2018 May;38(5):842-850. doi: 10.1111/liv.13604. Epub 2017 Oct 26.</citation>
    <PMID>28963781</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 19, 2015</study_first_submitted>
  <study_first_submitted_qc>February 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>January 14, 2020</last_update_submitted>
  <last_update_submitted_qc>January 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HDV, hepatitis delta</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis D</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

